Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 23;12(1):34.
doi: 10.1007/s13659-022-00354-z.

Therapeutic roles of plants for 15 hypothesised causal bases of Alzheimer's disease

Affiliations

Therapeutic roles of plants for 15 hypothesised causal bases of Alzheimer's disease

Sheena E B Tyler et al. Nat Prod Bioprospect. .

Abstract

Alzheimer's disease (AD) is progressive and ultimately fatal, with current drugs failing to reverse and cure it. This study aimed to find plant species which may provide therapeutic bioactivities targeted to causal agents proposed to be driving AD. A novel toolkit methodology was employed, whereby clinical symptoms were translated into categories recognized in ethnomedicine. These categories were applied to find plant species with therapeutic effects, mined from ethnomedical surveys. Survey locations were mapped to assess how this data is at risk. Bioactivities were found of therapeutic relevance to 15 hypothesised causal bases for AD. 107 species with an ethnological report of memory improvement demonstrated therapeutic activity for all these 15 causal bases. The majority of the surveys were found to reside within biodiversity hotspots (centres of high biodiversity under threat), with loss of traditional knowledge the most common threat. Our findings suggest that the documented plants provide a large resource of AD therapeutic potential. In demonstrating bioactivities targeted to these causal bases, such plants may have the capacity to reduce or reverse AD, with promise as drug leads to target multiple AD hallmarks. However, there is a need to preserve ethnomedical knowledge, and the habitats on which this knowledge depends.

Keywords: Alzheimer’s; Causal basis; Ethnomedicine; Medicinal plants; Traditional knowledge.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Distribution of ethnomedical surveys with potential therapeutic relevance for neurodegenerative diseases. The survey distribution on the map indicates that the surveys were located most commonly in Africa, Asia, Central and South America, suggesting an abundance of studies of ND relevance from those continents. There is also an abundance of surveys for certain countries (e.g., India, Nigeria), with the biggest cluster of surveys [40 in all] in India, Bangladesh and Pakistan combined. 90 out of 157 (57%) of the studies were found to reside within biodiversity hotspots and therefore are under threat. Inset: surveys located in Pacific islands

Similar articles

Cited by

References

    1. Nichols E, Szoeke CE, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, et al. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019;18(1):88–106. doi: 10.1016/S1474-4422(18)30403-4. - DOI - PMC - PubMed
    1. Yiannopoulou KG, Anastasiou AI, Zachariou V, Pelidou SH. Reasons for failed trials of disease-modifying treatments for Alzheimer disease and their contribution in recent research. Biomedicines. 2019;7(4):97. doi: 10.3390/biomedicines7040097. - DOI - PMC - PubMed
    1. Breijyeh Z, Karaman R. Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules. 2020;25(24):5789. doi: 10.3390/molecules25245789. - DOI - PMC - PubMed
    1. Dekker FA, Rüdiger SGD. The mitochondrial Hsp90 TRAP1 and Alzheimer’s disease. Front Mol Biosci. 2021;8:697913. doi: 10.3389/fmolb.2021.697913. - DOI - PMC - PubMed
    1. Lin P, Sun J, Cheng Q, Yang Y, Cordato D, Gao J. The development of pharmacological therapies for Alzheimer’s disease. Neurol Ther. 2021;10(2):609–626. doi: 10.1007/s40120-021-00282-z. - DOI - PMC - PubMed

LinkOut - more resources